SCHEMBL23948644

SCHEMBL23948644

c1ccc(-n2c3ccccc3c3c2ccc2c4cc5[nH]c6ccccc6c5cc4c4nc5ccccc5n4c23)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TOP2A P11388 1/20 0.37
KDM4E B2RXH2 5/20 0.37
MAPT P10636 3/20 0.37
LMNA P02545 1/20 0.37
TP53 P04637 1/20 0.37
POLB P06746 1/20 0.37
HSD17B10 Q99714 1/20 0.37
ALDH1A1 P00352 5/20 0.36
HPGD P15428 5/20 0.36
AHR P35869 1/20 0.36
KMT2A Q03164 3/20 0.35
MEN1 O00255 2/20 0.35
CAMKK1 Q8N5S9 2/20 0.34
CAMKK2 Q96RR4 2/20 0.34
CYP1A2 P05177 2/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34
CASP1 P29466 1/20 0.34
CYP2C19 P33261 1/20 0.34
CASP7 P55210 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23948418 0.84 KDM4E (0.37) KDM4EMAPTLMNATP53POLB
SCHEMBL23948639 0.84 CYP1A2 (0.40) KDM4EMAPTLMNATP53POLB
SCHEMBL21890437 0.83 KDM4E (0.47) KDM4EMAPTLMNATP53POLB
SCHEMBL21890639 0.82 KDM4E (0.37) KDM4EMAPTLMNATP53POLB
SCHEMBL23948420 0.82 GABRP (0.36) KDM4EMAPTLMNATP53POLB
SCHEMBL21890258 0.81 KDM4E (0.39) KDM4EMAPTLMNATP53POLB
SCHEMBL24046798 0.80 KDM4E (0.40) KDM4EMAPTLMNATP53POLB
SCHEMBL24046800 0.80 KDM4E (0.40) KDM4EMAPTLMNATP53POLB
SCHEMBL21890411 0.79 KDM4E (0.40) KDM4EMAPTLMNATP53POLB
SCHEMBL16067056 0.79 TOP2A (0.51) TOP2AKDM4EMAPTLMNATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210323963-A1 Functional Materials Based on Stable Chemical Structure ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY 2021-10-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210323963-A1 Functional Materials Based on Stable Chemical Structure TEAD4, TEAD2, TEAD1 TOP2A 2344/4885KDM4E 2817/4885MAPT 1313/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.